Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials in multiple sclerosis

J H Noseworthy1

  • 1Department of Neurology, Mayo Clinic, Rochester, MN 55905.

Current Opinion in Neurology and Neurosurgery
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disability as an outcome in MS clinical trials.

Neurology·2008
Same author

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Neurology·2005
Same author

Disability profile of MS did not change over 10 years in a population-based prevalence cohort.

Neurology·2004
Same author

Change in MS-related disability in a population-based cohort: a 10-year follow-up study.

Neurology·2004
Same author

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

Neurology·2003
Same author

International consensus statement on the use of disease-modifying agents in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2002
Same journal

Neuropharmacology.

Current opinion in neurology and neurosurgery·1993
Same journal

Disorders of the spinal cord and cauda equina.

Current opinion in neurology and neurosurgery·1993
Same journal

Autonomic disorders.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular and cell biology of addiction.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular mechanisms of trauma-induced neuronal degeneration.

Current opinion in neurology and neurosurgery·1993
Same journal

Excitatory amino acid receptors and epilepsy.

Current opinion in neurology and neurosurgery·1993
See all related articles

Modest progress has been made in multiple sclerosis (MS) treatments. While no cure exists, some medications offer symptomatic relief for MS complications and fatigue.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with limited disease-modifying treatments.
  • Current research focuses on managing symptoms and slowing disease progression.

Purpose of the Study:

  • To review recent advancements in multiple sclerosis treatment.
  • To evaluate the efficacy of existing and emerging therapies for MS and its complications.

Main Methods:

  • Meta-analysis of published studies on azathioprine.
  • Review of clinical trial data for various symptomatic treatments.

Main Results:

  • Azathioprine's marginal benefits are supported by meta-analysis.
  • Methylprednisolone may aid severe optic neuritis; prednisone may increase recurrence risk.

Related Experiment Videos

  • 4-Aminopyridine, 3,4-diaminopyridine, pemoline, and acetazolamide show potential for symptomatic relief.

    • Conclusions:

    • No treatment currently halts the active course of multiple sclerosis.
    • Emerging therapies offer promise for symptomatic management of MS complications, fatigue, and spasms.